UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

JSH guideline for tumors of hematopoietic and lymphoid tissues—lukemia: 4. Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN)

International journal of hematology, 2017-11, Vol.106 (5), p.591-611

Usui, Noriko

2017

Volltextzugriff (PDF)

Effect of Sulfur-Containing Side Chains on Transnitrosation of N-Nitroso Compounds of Thiazolidines

Heterocycles, 2023-02, Vol.106 (2), p.305

2023

Volltextzugriff (PDF)

Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy

International journal of hematology, 2021-11, Vol.114 (5), p.608-619

2021

Volltextzugriff (PDF)

Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211

Journal of clinical oncology, 2009-11, Vol.27 (33), p.5594-5600

2009

Volltextzugriff (PDF)

A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis

International journal of hematology, 2023-03, Vol.117 (3), p.409-420

2023

Volltextzugriff (PDF)

Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma

International journal of clinical oncology, 2022-01, Vol.27 (1), p.213-223

2022

Volltextzugriff (PDF)

A randomized, double‐blind trial of pegfilgrastim versus filgrastim for the management of neutropenia during CHASE(R) chemotherapy for malignant lymphoma

British journal of haematology, 2016-08, Vol.174 (4), p.563-570

2016

Volltextzugriff (PDF)

Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia

Haematologica (Roma), 2012-06, Vol.97 (6), p.903-906

2012

Volltextzugriff (PDF)

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group

Journal of clinical oncology, 2006-01, Vol.24 (3), p.460-466

2006

Volltextzugriff (PDF)

Antimutagenic components in Spatholobus suberectus Dunn against N -methyl- N -nitrosourea

Genes and environment, 2019-12, Vol.41 (1), p.22-9, Article 22

2019

Volltextzugriff (PDF)

Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia

Annals of hematology, 2020-12, Vol.99 (12), p.2787-2800

2020

Volltextzugriff (PDF)

Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia

International journal of hematology, 2019-04, Vol.109 (4), p.418-425

2019

Volltextzugriff (PDF)

Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia

British journal of haematology, 2005-03, Vol.128 (5), p.698-702

2005

Volltextzugriff (PDF)

Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study

International journal of hematology, 2017-09, Vol.106 (3), p.385-397

2017

Volltextzugriff (PDF)

Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes

Cancer science, 2011-09, Vol.102 (9), p.1680-1686

2011

Volltextzugriff (PDF)

Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review

Internal Medicine, 2017/03/15, Vol.56(6), pp.701-706

2017

Volltextzugriff (PDF)

Correction to: JSH guideline for tumors of hematopoietic and lymphoid tissues—lukemia: 4. Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN)

International journal of hematology, 2017-11, Vol.106 (5), p.725-725

Usui, Noriko

2017

Volltextzugriff (PDF)

Assessment of the acute toxicity of 16 veterinary drugs and a disinfectant to aquatic and soil organisms

Fundamental toxicological sciences, 2019, Vol.6 (9), p.333-340

2019

Volltextzugriff (PDF)

Long‐term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study

Cancer science, 2012-06, Vol.103 (6), p.1071-1078

2012

Volltextzugriff (PDF)

Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial

International journal of hematology, 2018-11, Vol.108 (5), p.499-509

2018

Volltextzugriff (PDF)

Hematologic Malignancies/Pediatric Malignancies Current Guidelines of Clinical Management and Drug Therapy for Hematological Malignancies

Gan to kagaku ryoho, 2019-05, Vol.46 (5), p.859

Usui, Noriko

2019

Volltextzugriff (PDF)

Prognostic biomarkers in patients with localized natural killer/T‐cell lymphoma treated with concurrent chemoradiotherapy

Cancer science, 2014-11, Vol.105 (11), p.1435-1441

2014

Volltextzugriff (PDF)

1 – 25 von 459

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(360)
Mit Volltextzugriff
(360)

Publikationsform

Sprache

Englisch
(381)
Japanisch
(88)

Erscheinungsjahr

n.n

Thema

Science & Technology
(229)
Humans
(202)
Life Sciences & Biomedicine
(192)
Female
(126)
Male
(117)
Middle Aged
(107)
Adult
(95)
Aged
(82)
Biological And Medical Sciences
(73)
Oncology
(65)
Hematology
(59)
Medical Sciences
(55)
Medicine
(46)
Treatment Outcome
(46)
Medicine & Public Health
(44)
Animals
(40)
Adolescent
(38)
Japan
(34)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(33)
Original Article
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(48)
International Journal Of Hematology
(37)
Rinsho Ketsueki
(28)
Rinshō Ketsueki
(28)
Gan To Kagaku Ryoho
(22)
Development, Growth & Differentiation
(9)
Endocrine Journal
(9)
Cancer Science
(6)
Nihon Naika Gakkai Zasshi
(6)
Annals Of Hematology
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

JSH guideline for tumors of hematopoietic and lymphoid tissues—lukemia: 4. Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN)

Effect of Sulfur-Containing Side Chains on Transnitrosation of N-Nitroso Compounds of Thiazolidines

Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy

Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211

A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis

Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma

A randomized, double‐blind trial of pegfilgrastim versus filgrastim for the management of neutropenia during CHASE(R) chemotherapy for malignant lymphoma

Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia

Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 study

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group

A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study

Antimutagenic components in Spatholobus suberectus Dunn against N -methyl- N -nitrosourea

Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study

Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia

Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia

Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia

Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study

Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes

Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review

Correction to: JSH guideline for tumors of hematopoietic and lymphoid tissues—lukemia: 4. Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN)

Assessment of the acute toxicity of 16 veterinary drugs and a disinfectant to aquatic and soil organisms

Long‐term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study

Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial

Hematologic Malignancies/Pediatric Malignancies Current Guidelines of Clinical Management and Drug Therapy for Hematological Malignancies

Prognostic biomarkers in patients with localized natural killer/T‐cell lymphoma treated with concurrent chemoradiotherapy

Suchergebnisse filtern